Factors Affecting the Environmentally Induced, Chronic Kidney Disease Of
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Inherited Renal Tubulopathies—Challenges and Controversies
G C A T T A C G G C A T genes Review Inherited Renal Tubulopathies—Challenges and Controversies Daniela Iancu 1,* and Emma Ashton 2 1 UCL-Centre for Nephrology, Royal Free Campus, University College London, Rowland Hill Street, London NW3 2PF, UK 2 Rare & Inherited Disease Laboratory, London North Genomic Laboratory Hub, Great Ormond Street Hospital for Children National Health Service Foundation Trust, Levels 4-6 Barclay House 37, Queen Square, London WC1N 3BH, UK; [email protected] * Correspondence: [email protected]; Tel.: +44-2381204172; Fax: +44-020-74726476 Received: 11 February 2020; Accepted: 29 February 2020; Published: 5 March 2020 Abstract: Electrolyte homeostasis is maintained by the kidney through a complex transport function mostly performed by specialized proteins distributed along the renal tubules. Pathogenic variants in the genes encoding these proteins impair this function and have consequences on the whole organism. Establishing a genetic diagnosis in patients with renal tubular dysfunction is a challenging task given the genetic and phenotypic heterogeneity, functional characteristics of the genes involved and the number of yet unknown causes. Part of these difficulties can be overcome by gathering large patient cohorts and applying high-throughput sequencing techniques combined with experimental work to prove functional impact. This approach has led to the identification of a number of genes but also generated controversies about proper interpretation of variants. In this article, we will highlight these challenges and controversies. Keywords: inherited tubulopathies; next generation sequencing; genetic heterogeneity; variant classification. 1. Introduction Mutations in genes that encode transporter proteins in the renal tubule alter kidney capacity to maintain homeostasis and cause diseases recognized under the generic name of inherited tubulopathies. -
Of Sri Lanka: an Analysis of Evidence to Date Fahim Aslam University of Wolverhampton, England, UK
Journal of Medical Case Reports and Case Series: Open Access _______________________________________________________________________________________ Mini Review Article Volume 1-Issue 1 Risk Factors Associated with Chronic Kidney Disease of Unknown Origin (Ckdu) in North Central Province (NCP) of Sri Lanka: An Analysis of Evidence to Date Fahim Aslam University of Wolverhampton, England, UK *Corresponding author: Fahim Aslam, University of Wolverhampton, England, UK Received date: 10 February 2020; Accepted date: 14 February 2020; Published date: 21 February 2020. Citation: Fahim Aslam (2020) Risk Factors Associated with Chronic Kidney Disease of Unknown Origin (Ckdu) in North Central Province (NCP) of Sri Lanka: An Analysis of Evidence to Date. J Med Case Rep Case Series 1 (1). Copyright: © 2020 Fahim Aslam. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Chronic kidney disease of unknown origin (CKDu) is a global burden among the agricultural communities, this is a non-communicable disease (NCD) which is asymptomatic and irreversible until latter stages of the disease. The disease has no common features unlike chronic kidney diseases (CKD’s) making early detection impossible in the patients. The most recent form of CKDu was reported in India, known as the Indian CKDu in late 2010’s. In Sri Lanka, CKDu is highly prevalent in the north central province of the country with nearly15.1%-22.9% presented with the disease. This region is a dry-zone in which agricultural and farming activities are carried out as the main occupation. -
Effects of Ramipril in Nondiabetic Nephropathy: Improved Parameters of Oxidatives Stress and Potential Modulation of Advanced Glycation End Products
Journal of Human Hypertension (2003) 17, 265–270 & 2003 Nature Publishing Group All rights reserved 0950-9240/03 $25.00 www.nature.com/jhh ORIGINAL ARITICLE Effects of ramipril in nondiabetic nephropathy: improved parameters of oxidatives stress and potential modulation of advanced glycation end products KSˇ ebekova´1, K Gazdı´kova´1, D Syrova´2, P Blazˇı´cˇek2, R Schinzel3, A Heidland3, V Spustova´1 and R Dzu´ rik 1Institute of Preventive and Clinical Medicine, Bratislava, Slovakia; 2Military Hospital, Bratislava, Slovakia; 3University Wuerzburg, Germany Enhanced oxidative stress is involved in the progres- patients on conventional therapy did not differ signifi- sion of renal disease. Since angiotensin converting cantly from the ramipril group, except for higher Hcy enzyme inhibitors (ACEI) have been shown to improve levels in the latter. Administration of ramipril resulted in the antioxidative defence, we investigated, in patients a drop in blood pressure and proteinuria, while creati- with nondiabetic nephropathy, the short-term effect of nine clearance remained the same. The fluorescent the ACEI ramipril on parameters of oxidative stress, AGEs exhibited a mild but significant decline, yet CML such as advanced glycation end products (AGEs), concentration was unchanged. The AOPP and malon- advanced oxidation protein products (AOPPs), homo- dialdehyde concentrations decreased, while a small rise cysteine (Hcy), and lipid peroxidation products. Ramipril in neopterin levels was evident after treatment. The (2.5–5.0 mg/day) was administered to 12 newly diag- mentioned parameters were not affected significantly in nosed patients for 2 months and data compared with a the conventionally treated patients. Evidence that rami- patient group under conventional therapy (diuretic/ pril administration results in a mild decline of fluores- b-blockers) and with age- and sex-matched healthy cent AGEs is herein presented for the first time. -
April 2020 Radar Diagnoses and Cohorts the Following Table Shows
RaDaR Diagnoses and Cohorts The following table shows which cohort to enter each patient into on RaDaR Diagnosis RaDaR Cohort Adenine Phosphoribosyltransferase Deficiency (APRT-D) APRT Deficiency AH amyloidosis MGRS AHL amyloidosis MGRS AL amyloidosis MGRS Alport Syndrome Carrier - Female heterozygote for X-linked Alport Alport Syndrome (COL4A5) Alport Syndrome Carrier - Heterozygote for autosomal Alport Alport Syndrome (COL4A3, COL4A4) Alport Syndrome Alport Anti-Glomerular Basement Membrane Disease (Goodpastures) Vasculitis Atypical Haemolytic Uraemic Syndrome (aHUS) aHUS Autoimmune distal renal tubular acidosis Tubulopathy Autosomal recessive distal renal tubular acidosis Tubulopathy Autosomal recessive proximal renal tubular acidosis Tubulopathy Autosomal Dominant Polycystic Kidney Disease (ARPKD) ADPKD Autosomal Dominant Tubulointerstitial Kidney Disease (ADTKD) ADTKD Autosomal Recessive Polycystic Kidney Disease (ARPKD) ARPKD/NPHP Bartters Syndrome Tubulopathy BK Nephropathy BK Nephropathy C3 Glomerulopathy MPGN C3 glomerulonephritis with monoclonal gammopathy MGRS Calciphylaxis Calciphylaxis Crystalglobulinaemia MGRS Crystal-storing histiocytosis MGRS Cystinosis Cystinosis Cystinuria Cystinuria Dense Deposit Disease (DDD) MPGN Dent Disease Dent & Lowe Denys-Drash Syndrome INS Dominant hypophosphatemia with nephrolithiasis or osteoporosis Tubulopathy Drug induced Fanconi syndrome Tubulopathy Drug induced hypomagnesemia Tubulopathy Drug induced Nephrogenic Diabetes Insipidus Tubulopathy Epilepsy, Ataxia, Sensorineural deafness, Tubulopathy -
Early Renal Damage Among Children Living in the Region of Highest Burden of Chronic Kidney Disease of Unknown Etiology (Ckdu) in Sri Lanka S
Agampodi et al. BMC Nephrology (2018) 19:115 https://doi.org/10.1186/s12882-018-0911-8 RESEARCH ARTICLE Open Access Early renal damage among children living in the region of highest burden of chronic kidney disease of unknown etiology (CKDu) in Sri Lanka S. B. Agampodi1, G. S. Amarasinghe1*, P. G. C. R. Naotunna1, C. S. Jayasumana2 and S. H. Siribaddana3 Abstract Background: Chronic kidney disease of unknown origin (CKDu) in Sri Lanka is grouped with several other epidemics of similar nature across the world as Chronic Interstitial Nephritis in Agricultural Communities (CINAC). In CKDu endemic countries, the focus has mainly been on adults. We hypothesized that studying distribution and factors associated with elevated urine albumin to creatinine ratio (UACR), an early marker of kidney injury, among children living in a CKDu endemic area may provide important clues about the onset and progression of the disease. Methods: This cross sectional study was performed in rural primary schools in North Central Province of Sri Lnaka, a CKDu high endemic region. Total of 2880 students aging 5 to 11 years from 67 schools were enrolled for urinalysis in a random spot urine sample. Bedside Schwartz formula was used to measure estimated glomerular filtration rate (eGFR) on all children with UACR > 30 mg/g in Polonnaruwa district and a group of age matched controls. A standard multiple linear regression using log transformed UACR as the dependent variable was performed. Mean eGFR were compared between UACR elevated group and controls using independent sample t test. Results: Median UACR was 10.3 mg/g. -
Chronic Kidney Disease of Unknown Etiology in Central America and Sri Lanka - Renal Morphology and Clinical Characteristics
From the Department of Clinical Science, Intervention and Technology (CLINTEC), Division of Renal Medicine, Karolinska Institutet, Stockholm, Sweden CHRONIC KIDNEY DISEASE OF UNKNOWN ETIOLOGY IN CENTRAL AMERICA AND SRI LANKA - RENAL MORPHOLOGY AND CLINICAL CHARACTERISTICS Julia Wijkström Stockholm 2017 Cover image by © Julia Wijkström (top) and © Annika Wernerson (bottom). Top image: View over a sugarcane field in El Salvador, May 2012. Bottom image: Kidney biopsy section from Study II (Nicaragua) stained with Periodic acid-Schiff. All previously published papers were reproduced with permission from the publisher. Published by Karolinska Institutet. Printed by Eprint AB 2017 © Julia Wijkström, 2017 ISBN 978-91-7676-785-6 Chronic Kidney Disease of Unknown Etiology in Central America and Sri Lanka - Renal Morphology and Clinical Characteristics THESIS FOR DOCTORAL DEGREE (Ph.D.) By Julia Wijkström Principal Supervisor: Opponent: Professor Annika Wernerson Senior Clinical Lecturer, PhD Ben Caplin Karolinska Institutet University College London Department of Clinical Science, Intervention and Centre for Nephrology Technology (CLINTEC) Division of Medicine Division of Renal Medicine Examination Board: Co-supervisor(s): Associate Professor Torbjörn Linde Professor Carl-Gustaf Elinder Uppsala University Karolinska Institutet Department of Medical Sciences Department of Clinical Science, Intervention and Division of Renal Medicine Technology (CLINTEC) Division of Renal Medicine Associate Professor Johan Mölne University of Gothenburg Associate -
Prime Mover and Key Therapeutic Target in Diabetic Kidney Disease
Diabetes Volume 66, April 2017 791 Richard E. Gilbert Proximal Tubulopathy: Prime Mover and Key Therapeutic Target in Diabetic Kidney Disease Diabetes 2017;66:791–800 | DOI: 10.2337/db16-0796 The current view of diabetic kidney disease, based on estimated glomerular filtration rate (eGFR) decline (2). In meticulously acquired ultrastructural morphometry and recognition of these findings, the term diabetic kidney the utility of measuring plasma creatinine and urinary al- disease rather than diabetic nephropathy is now commonly bumin, has been almost entirely focused on the glomer- used. On the background of recent advances in the role of ulus. While clearly of great importance, changes in the the proximal tubule as a prime mover in diabetic kidney PERSPECTIVES IN DIABETES glomerulus are not the major determinant of renal prog- pathology, this review highlights key recent developments. nosis in diabetes and may not be the primary event in the Published mostly in the general scientific and kidney- development of diabetic kidney disease either. Indeed, specific literature, these advances highlight the pivotal advances in biomarker discovery and a greater appreci- role this part of the nephron plays in the initiation, pro- ation of tubulointerstitial histopathology and the role of gression, staging, and therapeutic intervention in diabetic tubular hypoxia in the pathogenesis of chronic kidney kidney disease. From a pathogenetic perspective, as illus- disease have given us pause to reconsider the current trated in Fig. 1 and as elaborated on further in this review, “glomerulocentric” paradigm and focus attention on the proximal tubule that by virtue of the high energy require- tubular hypoxia as a consequence of increased energy de- ments and reliance on aerobic metabolism render it par- mands and reduced perfusion combine with nonhypoxia- ticularly susceptible to the derangements of the diabetic related forces to drive the development of tubular atrophy fi state. -
Prospective Biopsy-Based Study of CKD of Unknown Etiology in Sri Lanka
Article Prospective Biopsy-Based Study of CKD of Unknown Etiology in Sri Lanka Shuchi Anand,1 Maria E. Montez-Rath,1 Dinuka Adasooriya,2,3 Neelakanthi Ratnatunga,4 Neeraja Kambham,5 Abdool Wazil,2 Sulcohana Wijetunge,4 Zeid Badurdeen,3 Charaka Ratnayake,2 Nishamani Karunasena,2 Stephen L. Schensul,6 Penny Valhos,7 Lalarukh Haider,8 Vivek Bhalla,1 Adeera Levin,9 Paul H. Wise,10 Glenn M. Chertow,1 Michele Barry,11 Andrew Z. Fire,5 and Nishantha Nanayakkara2,3 1 Abstract Division of ’ Nephrology and Background and objectives A kidney disease of unknown cause is common in Sri Lanka s lowland (dry) region. Departments of Detailed clinical characterizations of patients with biopsy-proven disease are limited, and there is no current 5Pathology, consensus on criteria for a noninvasive diagnosis. 10Pediatrics, and 11Medicine, Stanford University School of Design, setting, participants, & measurements We designed a prospective study in a major Sri Lankan hospital Medicine, Palo Alto, servicing endemic areas to ascertain pathologic and clinical characteristics of and assess risk factors for primary California; 2Kandy tubulointerstitial kidney disease. We used logistic regression to determine whether common clinical character- Teaching Hospital, istics could be used to predict the presence of primary tubulointerstitial kidney disease on kidney biopsy. Kandy, Sri Lanka; 3Center for Education Research and Training Results From 600 new patients presenting to a tertiary nephrology clinic over the course of 1 year, 87 underwent on Kidney Diseases, kidney biopsy, and 43 (49%) had a biopsy diagnosis of primary tubulointerstitial kidney disease. On detailed Faculty of Medicine 4 biopsy review, 13 (30%) had evidence of moderate to severe active kidney disease, and six (15%) had evidence of and Department of Pathology, University moderate to severe chronic tubulointerstitial kidney disease. -
1 Fludrocortisone- a Treatment for Tubulopathy Post Paediatric Renal Transplantation: a National Paediatric Nephrology Unit Experience
Fludrocortisone- a treatment for tubulopathy post paediatric renal transplantation: A national paediatric nephrology unit experience Ali SR1, Shaheen I1, Young D2, Ramage I1, Maxwell H1, Hughes DA1, Athavale D1, Shaikh MG3 1. Department of Paediatric Nephrology, Royal Hospital for Children, 1345 Govan Road, Glasgow, UK, G51 4TF. 2. Department of Mathematics and Statistics, University of Strathclyde, 16 Richmond Street, Glasgow, UK, G1 1XQ. 3. Department of Paediatric Endocrinology and Diabetes, Royal Hospital for Children, 1345 Govan Road, Glasgow, UK, G51 4TF. Correspondence Dr MG Shaikh Department of Paediatric Endocrinology and Diabetes, Royal Hospital for Children, 1345 Govan Road, Glasgow, UK. G51 4TF Email: [email protected] Tel: 0141 451 6548 1 Fludrocortisone- a treatment for tubulopathy post paediatric renal transplantation: A national paediatric nephrology unit experience Ali SR, Shaheen I, Young D, Ramage I, Maxwell H, Hughes DA, Athavale D, Shaikh MG Pediatr Transplantation 2017 ABSTRACT Background Calcineurin inhibitors post renal transplantation are recognised to cause tubulopathies in the form of hyponatremia, hyperkalemia and acidosis. Sodium supplementation may be required, increasing medication burden and potentially resulting in poor compliance. Fludrocortisone has been beneficial in addressing tubulopathies in adult studies, with limited paediatric data available. Methods A retrospective review of data from an electronic renal database from December 2014 to January 2016. Results 47 post-transplant patients were reviewed with 23 (49%) patients on sodium chloride or bicarbonate. 9 patients, aged 8.3 years (range 4.9- 16.4) commenced fludrocortisone 22 months (range 1-80) after transplant and were followed up for 9 months (range 2-20). All patients stopped sodium bicarbonate; all had a reduction or no increase in total daily doses of sodium chloride. -
Advanced Oxidation Protein Products Contribute to Renal Tubulopathy Via Perturbation Of
Kidney360 Publish Ahead of Print, published on June 3, 2020 as doi:10.34067/KID.0000772019 Advanced oxidation protein products contribute to renal tubulopathy via perturbation of renal fatty acids Tadashi Imafuku1,2, Hiroshi Watanabe1,§, Takao Satoh3, Takashi Matsuzaka4,5, Tomoaki Inazumi6, Hiromasa Kato1, Shoma Tanaka1, Yuka Nakamura1, Takehiro Nakano1, Kai Tokumaru1, Hitoshi Maeda1, Ayumi Mukunoki7, Toru Takeo7, Naomi Nakagata7, Motoko Tanaka8, Kazutaka Matsushita8, Soken Tsuchiya6, Yukihiko Sugimoto6, Hitoshi Shimano4,9, Masafumi Fukagawa10, Toru Maruyama1,§ 1Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan 2Program for Leading Graduate Schools "HIGO (Health life science: Interdisciplinary and Glocal Oriented) Program", Kumamoto University, Kumamoto, Japan 3Kumamoto Industrial Research Institute, Kumamoto, Japan 4Department of Internal Medicine (Endocrinology and Metabolism), Faculty of Medicine, University of Tsukuba, Ibaraki, Japan 5Transborder Medical Research Center, University of Tsukuba, Ibaraki, Japan 6Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan 7Division of Reproductive Engineering, Center for Animal Resources and Development (CARD), Kumamoto University, Kumamoto, Japan 8Department of Nephrology, Akebono Clinic, Kumamoto, Japan. 1 Copyright 2020 by American Society of Nephrology. 9AMED-CREST, Japan Agency for Medical Research and Development (AMED), Tokyo, Japan 10Division of Nephrology, -
Reversible Proximal Renal Tubular Dysfunction After One-Time Ifosfamide Exposure
Cancer Res Treat. 2010;42(4):244-246 DOI 10.4143/crt.2010.42.4.244 Case Report Open Access Reversible Proximal Renal Tubular Dysfunction after One-Time Ifosfamide Exposure Young Il Kim, M.D. The alkylating agent ifosfamide is an anti-neoplastic used to treat various pediatric and adult Ju Young Yoon, M.D. malignancies. Its potential urologic toxicities include glomerulopathy, tubulopathy and hemorrhagic cystitis. This report describes a case of proximal renal tubular dysfunction and Jun Eul Hwang, M.D. hemorrhagic cystitis in a 67-year-old male given ifosfamide for epitheloid sarcoma. He was Hyun Jeong Shim, M.D. also receiving an oral hypoglycemic agent for type 2 diabetes mellitus and had a baseline Woo Kyun Bae, M.D. glomerular filtration rate of 51.5 mL/min/1.73 m2. Despite mesna prophylaxis, the patient ex- Sang Hee Cho, M.D. perienced dysuria and gross hematuria after a single course of ifosfamide plus adriamycin. Ik-Joo Chung, M.D. The abrupt renal impairment and serum/urine electrolyte imbalances that ensued were consistent with Fanconi’s syndrome. However, normal renal function and electrolyte status were restored within 14 days, simply through supportive measures. A score of 8 by Naranjo Department of Hematology-Oncology, adverse drug reaction probability scale indicated these complications were most likely Chonnam National University Medical School, Gwangju, Korea treatment-related, although they developed without known predisposing factors. The currently undefined role of diabetic nephropathy in adult ifosfamide nephrotoxicity -
International Expert Consultation on Chronic Kidney Disease of Unknown Etiology
International Expert Consultation on Chronic Kidney Disease of Unknown Etiology 1 2 International Expert Consultation on Chronic Kidney Disease of Unknown Etiology Colombo, Sri Lanka 27–29 April 2016 3 WHO Library Cataloguing-in-Publication data World Health Organization, Country office for Sri Lanka . Report of the International Expert Consultation on Chronic Kidney Disease of unknown etiology (CKDu) in Sri Lanka 1. Etiology 2. Agrochemicals 3. Metals, Heavy 4. Water 5. Epidemiology 6. Sri Lanka . I. Title ISBN 978-955-0261-15-4 (NLM classification: WJ 342) ©World Health Organization, 2016 All rights reserved. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader.